Topography of putaminal degeneration in multiple system atrophy: A diffusion magnetic resonance study
暂无分享,去创建一个
W. Poewe | C. Kremser | M. Schocke | C. Scherfler | K. Seppi | G. Wenning | W. Jaschke | R. Esterhammer | Kathrin Prennschuetz-Schuetzenau | K. Mair | A. Muigg
[1] P Sandroni,et al. Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.
[2] Klaus Seppi,et al. Progression of parkinsonism in multiple system atrophy , 2005, Journal of Neurology.
[3] Werner Jaschke,et al. Comparison of diffusion‐weighted imaging and [123I]IBZM‐SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease , 2004, Movement disorders : official journal of the Movement Disorder Society.
[4] Christian Kremser,et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease , 2004, NeuroImage.
[5] C. Büchel,et al. Voxel‐based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy , 2003, Movement disorders : official journal of the Movement Disorder Society.
[6] Juha O Rinne,et al. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET , 2003, Synapse.
[7] Denis Le Bihan,et al. Looking into the functional architecture of the brain with diffusion MRI , 2003, Nature Reviews Neuroscience.
[8] M. Savoiardo. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging , 2003, Neurological Sciences.
[9] C Kremser,et al. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.
[10] Paola Piccini,et al. Clinical and subclinical dopaminergic dysfunction in PARK6‐linked parkinsonism: An 18F‐dopa PET study , 2002, Annals of neurology.
[11] C. Mathias,et al. Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? , 2002, Neurology.
[12] E. Louis. Vaccines to treat encephalitis lethargica: human experiments at the Neurological Institute of New York, 1929-1940. , 2002, Archives of neurology.
[13] B. Drayer,et al. Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. , 2002, Archives of neurology.
[14] Masanori Ichise,et al. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP , 2002, Movement disorders : official journal of the Movement Disorder Society.
[15] K. Seppi,et al. A novel grading scale for striatonigral degeneration (multiple system atrophy) , 2002, Journal of Neural Transmission.
[16] C Kremser,et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD , 2002, Neurology.
[17] Merja Haaparanta,et al. Rate of progression in Parkinson's disease: A 6‐[18F]fluoro‐L‐dopa PET study , 2001, Movement disorders : official journal of the Movement Disorder Society.
[18] H U Rehman,et al. Multiple system atrophy , 2001, Postgraduate medical journal.
[19] F. Tison,et al. Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.
[20] M. Skalej,et al. Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.
[21] I Litvan,et al. Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.
[22] A J Lees,et al. Clinical usefulness of magnetic resonance imaging in multiple system atrophy , 1998, Journal of neurology, neurosurgery, and psychiatry.
[23] S. Gilman,et al. Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology. , 1998, Clinical autonomic research : official journal of the Clinical Autonomic Research Society.
[24] R P Maguire,et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. , 1997, Brain : a journal of neurology.
[25] Francesco Federico,et al. Proton magnetic resonance spectroscopy in parkinson's disease and atypical parkinsonian disorders , 1997 .
[26] I Litvan,et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. , 1997, Archives of neurology.
[27] C. Marsden,et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy , 1995, Annals of neurology.
[28] Y. Hashizume,et al. Neuronal cell loss of the striatonigral system in multiple system atrophy , 1993, Journal of the Neurological Sciences.
[29] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[30] Richard S. J. Frackowiak,et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomography , 1992, Annals of neurology.
[31] A. Lees,et al. Striatonigral degeneration. A clinicopathological study. , 1990, Brain : a journal of neurology.
[32] R I Grossman,et al. Magnetic resonance imaging in Parkinson's disease and parkinsonian syndromes , 1989, Neurology.